Changing epidemiology of invasive candidiasis in intensive care units-Much ado about nothing?

Critical Care Medicine

Volumn 36, Issue 7, 2008, Pages 2188-2189

  Sobel, Jack D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Candida; Epidemiology; Fluconazole susceptibility; Non albicans Candida spp

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ECHINOCANDIN; FLUCONAZOLE; PYRROLE DERIVATIVE;

ANTIFUNGAL RESISTANCE; CANDIDA GLABRATA; CANDIDIASIS; DRUG COST; EDITORIAL; EPIDEMIOLOGY; HOST RESISTANCE; HUMAN; INTENSIVE CARE UNIT; INVASIVE CANDIDIASIS; MINIMUM INHIBITORY CONCENTRATION; NEUTROPENIA; PRIORITY JOURNAL; RISK FACTOR; CANDIDA; CLASSIFICATION; ISOLATION AND PURIFICATION; NOTE; STATISTICS;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; ECHINOCANDINS; HUMANS; INTENSIVE CARE UNITS;

EID: 47249128157     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318170fa45     Document Type: Editorial

References (14)

1. Eggimann P, Garbino J, Pittet D: Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 2003; 3:685-702
2. Pfaller MA, Diekema DJ: Epidemiology of invasive candidiasis: A persistent public health problem. Clin Microbiol Rev 2007; 20:133-163
3. Trick WE, Fridkin SK, Edwards JR, et al: National Nosocomial Infections Surveillance System Hospitals. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989 -1999. Clin Infect Dis 2002; 35:627- 630
4. Tortorano AM, Caspani L, Rigoni AL, et al: Candidosis in the intensive care unit: A 20-year survey. J Hosp Infect 2004; 57:8-13
5. Leleu G, Aegerter P, Guidet B: College des Utilisateurs de Base de Données en Réanima-tion. Systemic candidiasis in intensive care units: a multicenter, matched-cohort study. J Crit Care 2002; 17:168-175
6. Rangel-Frausto MS, Wiblin T, Blumberg HM, et al: National epidemiology of mycoses survey (NEMIS): Variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 1999; 29:253-258
7. Hajjeh RA, Sofair AN, Harrison LH, et al: Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol 2004; 42:1519-1527
8. Abi-Said D, Anaissie E, Uzun O, et al: The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 1997; 24:1122-1128
9. Chow JK, Golon Y, Ruthazer R, et al: Risk factors for albicans and non-albicans candi-demia in the intensive care unit. Crit Care Med 2008; 36:1993-1998
10. Shorr AF, Lazarus DR, Sherner JH, et al: Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia Crit Care Med 2007; 35:1077-1083
11. Playford E, Marriott D, Nguyen Q, et al: Candi-demia in non-neutropenic critically ill patients - risk factors for non-albicans Candida spp. Crit Care Med 2008; 36:2034 -2039
12. Pappas PG, Rex JH, Sobel JD, et al: Infectious Diseases Society of America. Guidelines for treatment of candidiasis. Clin Infect Dis 2004; 38:161-189
13. Lin MY, Carmeli Y, Zumsteg J, et al: Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: A case-case-control study. Antimicrob Agents Chemother 2005; 49:4555-4560
14. Shepard JR, Addison RM, Alexander BD, et al: Multicenter evaluation of the Candida albi-cans/Candida glabrata peptide nucleic acid fluorescent in situ hybridization method for simultaneous dual-color identification of C. albicans and C. glabrata directly from blood culture bottles. J Clin Microbiol 2008; 46:50-55